Opening by the Chairperson (ID 1805)
Newly diagnosed advanced EGFRm NSCLC: What information will help improve our treatment decision? (ID 1806)
Planning the patient journey: How can we maximise all of the treatment opportunities? (ID 1807)
Exploring treatment options beyond progression (ID 1808)
Expert opinions on hot topics: A panel discussion (ID 1880)
Your opportunity to question the panel further: Audience Q & A (ID 1809)
Closing remarks (ID 1810)